Innovation Theaters Schedule

Grab a Bite and get informed at the Innovation Theaters* located in the exhibit hall, booth #110 and #127. Don’t miss out on participating in a non-CME informative lunch or snack break discussion about the latest clinical information as it relates to a specific disease state. 

Thursday, April 30

Morning Break - 10:30-11:15 a.m.
A Short History of PCSK9 Discovery and Research

James A. Underberg, MD

Supported by Sanofi Regeneron

Morning Break - 10:30-11:15 a.m.
New Advancements in Insulin Therapy

The “New Advancements in Insulin Therapy” presentation provides an overview, the pharmacodynamics, pharmacokinetics, and clinical studies on new insulin therapy. This introductory presentation also includes information on adverse reactions, important safety and use, and the use of this insulin therapy with specific populations.  

Supported by Sanofi

Lunch - 1:00-1:45 p.m.
The Prevalence of Dyslipidemia in Diabetes: Cholesterol Management and the Role of PCSK9 in Cholesterol Homeostasis

This presentation will review the prevalence of dyslipidemia in patients with diabetes mellitus, explain the role of PCSK9 in LDL-C metabolism and discuss lessons from human genetics.

Michael Bloch, MD

Medical Director, Vascular Care at Renown Institute for Heart and Vascular Health

Reno, NV

Supported by Amgen

Lunch - 1:00-1:45 p.m.
Advances in Sleep Apnea Diagnosis and Therapy: New Options for Your Primary Care Patients

The clinical evidence is well documented on how treating obstructive sleep apnea (OSA) improves underlying comorbid conditions and reduces mortality.  Learn more about the importance of treating OSA, new diagnostic options with home sleep testing, gender-specific options, and how new PAP comfort features can improve patient adherence.

Paul Doghramji, MD, FAAFP

Collegeville Family Practice

Collegeville, PA

Supported by ResMed

Afternoon Break - 3:45-4:30 p.m.
HARVONI: Changing What is Possible With a Simple Treatment Regimen

Paul J. Gaglio, MD

Professor of Clinical Medicine; Medical Director: Adult Liver Transplantation, Division of Hepatology, Montefiore Medical Center and Albert Einstein College of Medicine

Bronx, NY

Supported by Gilead 

Friday, May 1

Morning Break - 10:30-11:15 a.m.
Discussion of an Anticoagulant for Treatment of Nonvalvular Atrial Fibrillation and Venous Thromboembolism

This presentation will focus on the introduction of an oral anticoagulation treatment option. During the program, you will learn about the treatment’s clinical profile and will be able to review important clinical considerations. Topics that will be discussed include key results from pivotal NVAF and VTE trials, recommended dosing and administration, and highlights of key safety information, including adverse events and boxed warnings.

Alpesh Amin, MD, MBA

Professor of Medicine, University of California, Irvine

Supported by Daiichi Sankyo, Inc.

Morning Break - 10:45-11:15 a.m.
Pneumococcal Disease and Invasive Disease in Adults: Help Protect Patients Aged 65+ in Your Practice

Yoav Golan, MD

Tufts Medical Center

Boston, MA

Supported by Pfizer

Lunch - 1:00-1:45 p.m.
Addressing Chronic Weight Management with Targeted Pharmacotherapy

This session will present a novel pharmacotherapeutic option for addressing the obesity epidemic. An expert in the field of chronic weight management will describe the benefits and limitations of current management strategies, as well as discuss the mechanism of action, clinical safety data, and clinical efficacy data for a targeted pharmacotherapy treatment option.

Lawrence E. Mieczkowski, MD

Center For Cardiometabolics

Kettering, OH

Supported by Eisai

Lunch - 1:00-1:45 p.m. 
Exploring Risk Reduction in Thrombosis

This lecture will discuss treatment options for patients with deep vein thrombosis and pulmonary embolism, and how they can reduce the risk of recurrent thrombotic events. It will also present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation.

Joseph K. Choo, MD, FACC

Staff Cardiologist, Christ Hospital Physicians, Ohio Heart and Vascular, Cincinnati, Ohio

Supported by Janssen Pharmaceuticals, Inc

Afternoon Break - 3:45-4:30 p.m.
Hepatic Encephalopathy: Understanding the CNS Dysfunction as a Result of Cirrhosis

Steven Flamm, MD

Chief, Liver Transplantation  Northwestern Memorial Hospital; Professor of Medicine & Surgery, Northwestern University; Feinberg School of Medicine

Chicago, Illinois

Supported by Salix Pharmaceuticals

*Innovation Theater presentations are independently organized and are not an official part of the Internal Medicine Meeting 2015 educational program.